Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinomaTim Underwood, Gareth J. Thomas|The Journal of Pathology|2014Cited by 182
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trialNalinie Joharatnam‐Hogan, R. Steele, John Bridgewater et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 64
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard Turkington, Richard D. Kennedy, Laura A. Knight et al.|Gut|2019Cited by 27
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblastsBenjamin P. Sharpe, Tim Underwood|Cell Reports Medicine|2022Cited by 24
Patient-derived tumor organoid and fibroblast assembloid models for interrogation of the tumor microenvironment in esophageal adenocarcinomaBenjamin P. Sharpe, Tim Underwood|Cell Reports Methods|2024Cited by 10